Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, PER

NUTRACEUTICAL INNOVATOR STEMREGEN® BOLSTERS LEADERSHIP TEAM WITH INDUSTRY INSIDERS FOCUSED ON EXPANSION GOALS


AUSTIN, Texas, April 25, 2024 /PRNewswire/ -- STEMREGEN®, the pioneer in stem cell science creating the most powerful supplements that support the body's innate repair system by optimizing stem cell function in the body, announces leadership team changes aligned around the company's business objectives and growth trajectory. Its flagship product is a clinically tested blend of natural ingredients that support stem cell release and migration, fostering healthy aging and rejuvenation from within.

Founder Christian Drapeau MSc., the neurophysiology scientist to first propose and publish the hypothesis that stem cells constitute the "repair system" of the body, will become Chief Science Officer allowing him to focus on the brand's cutting-edge stem cell research and educate industry insiders and consumers about the future and potential for stem cell health.

Drapeau named Ryan Riley, former Chief Executive Officer of Microbe Formulas and CellCore Biosciences, as his successor as CEO. Riley was previously an advisor to the company and brings deep industry experience leading companies through stages of prolific growth.

In addition, Nicholas Zaldastani has been elected Chairman of the Board. Zaldastani is a mentor capitalist who has invested in and led technology and health and wellness companies such as Oracle, SABA, World Energy Solutions, Salary.com, CESS.cloud, and the brain fitness company BrainTap.

"I'm proud of Stemregen's deep commitment to science and quality standards and of the business growth we've created as a result, and I'm excited for our growing, deeply experienced leadership team to capitalize and continue the positive momentum," said Christian Drapeau, MSc., Stemregen Founder and Chief Science Officer. "I'm looking forward to my continued focus on stem cell research and to uncovering what's possible when we support the body's innate repair system so we can share our findings and products with the world."

For more information about the brand and its scientific inventor and founder, follow @StemCellChristian on TikTok and Instagram, and @Stemregen on Instagram.

ABOUT STEMREGEN®
Stemregen creates supplements containing plant extracts sourced from around the globe that have been documented to naturally increase the number of circulating stem cells in the human body. Its core product includes Stemberrytm; a sea buckthorn berry extract, Stemaloetm; a proprietary complex with aloe from a unique source, and other ingredients. One serving of two capsules was documented to trigger the release of an average of 10 million additional stem cells from bone marrow to help support the body's innate repair system, paving the way for healthy aging with optimal health and longevity.
https://www.stemregen.co/

PRESS CONTACT
Alafair Hall
[email protected]
415.730.9044

SOURCE STEMREGEN


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: